Taken together, our results suggested that the NRF2-ATF3/4-CHAC1 pathway-mediated antioxidant response might be associated with bortezomib cytotoxicity in MM cells increased by DHA/EPA pretreatment (Figure 6B). Here, NFE2L2 is linked to Miyoshi myopathy.